According to Reuters, the US Food and Drug Administration (FDA) announced last month that it would be requiring companies to include tracking codes on medical devices, allowing the agency to monitor them for safety issues or

The U.S. Food and Drug Administration (FDA) has announced the recall of the Stryker Spine OASYS Midline Occiput Plate over a potentially dangerous side effect, signaling that there is a “reasonable possibility” that the product

According to the Associated Press, the U.S. Food and Drug Administration (FDA) is warning the public that certain cardiac defibrillators by Philips Healthcare may fail to deliver needed shock treatment during emergencies. The defibrillators are used to

The U.S. Food and Drug Administration (FDA) announced the recall recently of Nephron Pharmaceuticals’ over-the-counter bronchodilator and inhaler device due to misleading labeling and chocking concerns. The agency said that the product’s label encourages consumers

The US Food and Drug Administration (FDA) has announced a plan to conduct a safety assessment of the blood thinner Pradaxa (dabigatran).  The FDA describes the assessment as “a one-time assessment of selected safety outcomes in adults with atrial

Lawsuit Deadline: ONE WEEK To File a Fungal Meningitis Claim.  A $100 million fund has been set up to compensate victims of the fungal meningitis outbreak, but victims and their families have only until January 15,

The judge in a C.R. Bard transvaginal mesh lawsuit has upheld a jury verdict awarding a woman $250,000 in compensatory damages and $1.75 million in punitive damages. On October 18, Judge Joseph R. Goodwin upheld

The DePuy ASR MDL has reached a point of settlement for many plaintiffs. On Tuesday, November 19th, the parties announced a resolution for ASR patients who were revised before August 31, 2013. For the past

The New York Times (9/13, Thomas) reports that the recalls of a lot of Risperdal Consta, (an injectable antipsychotic treatment) and 200,000 bottles of liquid Motrin for infants, have raised new questions about whether Johnson & Johnson “has moved

According to the Washington Post, physicians who wrote guidelines aimed at preventing heart attacks and strokes are having to defend against strong criticism that the guidelines overestimate the risk for certain groups of people.  The formula would allegedly expand the